However, some study reported that thiazolidinediones (i.e., PPAR-γ agonists) led to an increase in plasma SHBG levels and improved anovulation and ovulatory dysfunction and infertility in patients with PCOS [34, 40]. Here, SHBG is linked to polycystic ovary syndrome.